DISCOVER
eISF
THE ELECTRONIC INVESTIGATOR SITE FILE
The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements. These documents include the protocol, informed consent forms, study reports, lab results, and other documentation related to the trial.
Leads to this page
The eISF is stored in a secure, web-based system that is accessible to authorized personnel only
The use of eISFs has several advantages over paper-based ISFs :
• efficiency in document management
• increases accuracy and completeness of data
• enhances security of sensitive information
• facilitates remote monitoring of study sites
• real-time data access and sharing between sites, sponsors, and regulatory agencies
Theuse of eISFs represents a significant step forward in the conduct of clinical research, enabling faster and more efficient trial management while ensuring compliance with regulatory and ethical standards.
LATEST NEWSOUR NEWS >
February 27, 2025
18 – 20 march – Basel, Switzerland Register Now DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and […]
February 27, 2025
Med City News From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out. Somewhere in a laboratory, tucked away in its vessel, […]
February 27, 2025
Applied Clinical Trials Artificial intelligence (AI) is the biggest transformation in life sciences in the last 25 years—an advancement akin to mapping the human genome, with potential for a much higher rate of scientific breakthroughs over the next decade. But there’s still a lot to consider when applying AI to clinical development and product commercialization, […]